References
Agnello, V., Winchester, R. J., Kunkel, H. G.: Precipitin reactions of the C1q component of complement with aggregated γ-globulin and immune complexes in gel diffusion. Immunology 19, 909 (1970)
Alper, C. A., Abramson, N., Johnston, R. B. Jr.: Increased susceptibility to infection associated with abnormalities of the third component of complement (C3). N. Engl. J. Med. 283, 349 (1970)
Asghar, S. S., Cormane, R. H.: Vasculitis. In: Immunological aspects of skin diseases, (ed.) Fry, L., Seah, P. P., pp. 192–233. Lancaster: Medical a. Technical Publishing Co. Ltd. 1974
Cochrane, C. G., Weigle, W. O.: The cutaneous reaction to soluble antigen-antibody complexes. A comparison with the Arthus phenomenon. J. Exp. Med. 108, 591 (1958)
Conn, D. L., McDuffie, F. C., Holley, K. E., Schroeter, A. L.: Immunologic mechanisms in systemic vasculitis. Mayo Clin. Proc. 51, 511 (1976)
Daha, M. R., Fearon, D. T., Austen, K. F.: C3 requirements for formation of alternative pathway C5 convertase. J. Immunology 117, 630 (1976)
Diaz, L. A., Provost, T. T., Tomasi, T. B., Jr.: Pustular necrotizing angiitis. Arch. Dermatol. (Chic.) 108, 114 (1973)
Fine, P. P.: Activation of the classic and alternative complement pathways by endotoxin. J. Immunol. 112, 763 (1974)
Gallin, J. I., Clark, R. A., Frank, M. M.: Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways. Clin. Immunol. Immunopathol. 3, 334 (1975)
Gewurz, H., Shin, H. S., Mergenhagen, S. E.: Interaction of complement system with endotoxin lipopolysaccharide: consumption of each of the six terminal complement components. J. Exp. Med. 128, 1049 (1968)
Gill, F. A., Cole, R. M.: The fate of a bacterial antigen (streptococcal M protein) after phagocytosis by macrophages. J. Immunol. 94, 898 (1965)
Goers, J. W., Ziccardi, R. J., Schumaker, V. N., Glovsky, M. M.: The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex. J. Immunol. 118, 2182 (1977)
Heymer, B., Haferkamp, O., Schmidt, W. C.: Präparation und Anwendung FITC-markierter Streptokokkenzellwand-Kohlenhydrate. Z. Immunitätsforsch., Allerg. Klin. Immunol. 140, 457 (1970)
Heymer, B., Bültmann, B., Haferkamp, O.: Toxicity of streptococcal mucopeptides in vivo and in vitro. J. Immunol. 106, 858 (1972)
Heymer, B., Schäfer, H., Haferkamp, O.: Vergleichende elektronenoptische und biochemische Untersuchungen über die Wirkung einer Streptomyces albus Endo-N-Acetyl-Muramidase auf die Streptokokkenzellwand. Med. Microbiol. Immunol. 158, 193 (1973)
Heymer, B., Bültmann, B., Schachenmayr, W., Spanel, R., Haferkamp, O., Schmidt, W. C.: Migration inhibition of rat peritoneal cells induced by streptococcal mucopeptides. Characteristics of the reaction and properties of the mucopeptide preparations. J. Immunol. 116, 1743 (1973)
Inai, S., Nagaki, K., Ebisu, S., Kato, K., Kotani, S., Misaki, A.: Activation of the alternative complement pathway by water-insoluble glucans of streptococcus mutans: the relation between their chemical structures and activating potencies. J. Immunol. 117, 1256 (1976)
Kantor, F. S.: Fibrinogen precipitation by streptococcal M protein. II. Renal lesions induced by intravenous injection of M protein into mice and rats. J. Exp. Med. 121, 861 (1965)
Linscott, W. D., Hansen, S. S.: Non-complement-fixing IgM antibodies in the guinea pig. J. Immunol. 103, 423 (1969)
Marcus, R. L., Shin, H. S., Mayer, M. M.: An alternative complement pathway: C3 cleaving activity, not due to C4, 2a on endotoxic lipopolysaccharide after treatment with guinea pig serum. Proc. Nat. Acad. Sci. 68, 1351 (1971)
McCombs, R. P.: Systemic “allergic” vasculitis. Clinical and pathological relationships. JAMA 194, 1059 (1965)
Parish, W. E., Rhodes, E. L.: Bacterial antigens and aggregated gamma globulin in the lesions of nodular vasculitis. Br. J. Dermatol. 79, 131 (1967)
Ramsay, C., Fry, L.: Allergic vasculitis: Clinical and histological features and incidence of renal involvement. Br. J. Dermatol. 81, 96 (1969)
Schmidt, W. C.: Immunological reactions of group A streptococcus polysaccharide. Bact. Proc. (1963) 73 — Abstract M76
Schmidt, W. C., Moore, D.: The determination of antibody to group A streptococcal polysaccharide in human sera by hemagglutination. J. Exp. Med. 121, 793 (1965)
Schroeter, A. L., Copeman, P. W. M., Jordon, R. E., Mitchell Sams, W., Winkelmann, R. K.: Immunofluorescence of cutaneous vasculitis associated with systemic disease. Arch. Dermatol. (Chic.) 104, 254 (1971)
Snyderman, R., Shin, H. S., Phillips, J. K., Gewurz, H., Mergenhagen, S. E.: A neutrophil chemotactic factor derived from C′5 upon interaction of guinea pig serum with endotoxin. J. Immunol. 103, 413 (1969)
Sutherland, J. C., Markham, R. V., Jr., Mardiney, M. R., Jr.: Subclinical immune complexes in the glomeruli of kidneys postmortem. Am. J. Med. 57, 536 (1974)
Tappeiner, G., O'Loughlin, S., Mackel, S., Kahl, J., Jordon, R. E.: Studies of immune complexes in cutaneous vasculitis. J. Invest. Dermatol. 70, 234 (1978) — Abstract of ESDR program
Ward, P. A., Cochrane, C. G.: Bound complement and immunologic injury of blood vessels. J. Exp. Med. 121, 215 (1965)
Weidner, F.: Immunofluorescent investigations in cutaneous vasculitis. I. Histotopical demonstration of complement/complement factors. Arch. Dermatol. Res. 253, 249 (1975)
Weidner, F.: Die kutanen hyperergischen Angiitiden (Vaskulitiden). In: Ergebnisse der Angiologie, Bd. 9, (Hrsg.) Klüken, N.. Stuttgart, New York: F. K. Schattauer 1976
Wilkinson, D. S.: Some clinical manifestations and associations of “allergic” vasculitis. Br. J. Dermatol. 77, 186 (1965)
Winkelstein, J. A., Tomasz, A.: Activation of the alternative pathway by pneumococcal cell walls. J. Immunol. 118, 451 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weidner, F. Erythema elevatum diutinum. Arch Dermatol Res 264, 97–100 (1979). https://doi.org/10.1007/BF00417285
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00417285